NEW MANAGEMENT STRATEGIES FOR HEART FAILURE
3:45 pm - 5:00 pm, Astor Ballroom - 7th Floor
Course Code: F-11
Speaker: ROBERT N. SLADEN, M.D.
Dr. Sladen - Receives funded research support from Eli Lilly Company and Scios Inc. as well as consultant fees/salary from Hospira, Inc. (Japan) and Orion Pharma.
Objective(s):
Objective(s):
° Describe new mechanical and pharmacologic strategies to manage patients with heart failure;
° Incorporate these strategies in various clinical settings;
° Formulate a plan of anesthetic care for patients whose heart failure is being managed using newer mechanical and pharmacologic strategies.
Review the Pharmacological Approach To This Issue
An Update on The Mechanical Support
|
